Fingerprint
Dive into the research topics of 'Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
Hikaru Ota, Jun Takeuchi, Yuyako Nakano, Etsuyo Horiguchi, Yosuke Taki, Yasuki Ito, Hiroko Terasaki, Koji M. Nishiguchi, Keiko Kataoka
Research output: Contribution to journal › Article › peer-review
20
Citations
(Scopus)